Drug Therapy for Melanoma: Current Updates and Future Prospects

Area of Science:

• Oncology
• Dermatology
• Immunology

Background:

• Melanoma treatment has evolved from 'incurable' to manageable with modern therapies.
• Advanced-stage melanoma historically had a poor prognosis, but new treatments offer hope.

Purpose of the Study:

• To review current melanoma drug therapies, including immunotherapy and targeted treatments.
• To discuss future directions and challenges in melanoma treatment.
• To highlight the importance of personalized medicine in melanoma care.

Main Methods:

• Comprehensive literature review of published studies on melanoma drug therapy.
• Analysis of current treatment landscape, including immunotherapies, targeted therapies, vaccines, cell therapies, and intratumoral agents.
• Discussion of factors influencing treatment selection and optimization.

Main Results:

• Immune checkpoint inhibitors and molecular targeted therapies have transformed melanoma treatment.
• Immunotherapy has enabled long-term survival in advanced melanoma.
• Adverse toxicities are associated with new treatments, necessitating careful patient selection and management.

Conclusions:

• Personalized therapy, guided by patient-specific factors like BRAF mutations and metastases, is key to optimizing melanoma treatment.
• Guideline-recommended algorithms should be followed, with adjustments for individual patient needs to minimize adverse effects.
• Ongoing research aims to overcome current treatment limitations and further improve melanoma outcomes.